The Cooper Companies, Inc. COO Office and surgical — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Cooper Companies, Inc.'s office and surgical — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Cooper Companies, Inc.'s office and surgical — net sales?
- The Cooper Companies, Inc. (COO) reported office and surgical — net sales of $214.2M in Q1 2026.
- How has The Cooper Companies, Inc.'s office and surgical — net sales changed year-over-year?
- The Cooper Companies, Inc.'s office and surgical — net sales increased by 4.1% year-over-year, from $205.8M to $214.2M.
- What is the long-term trend for The Cooper Companies, Inc.'s office and surgical — net sales?
- Over 3 years (2022 to 2025), The Cooper Companies, Inc.'s office and surgical — net sales has grown at a 9.2% compound annual growth rate (CAGR), from $633.6M to $824M.
- What does office and surgical — net sales mean?
- Total revenue generated from the sale of medical office and surgical products.
- How do you interpret office and surgical — net sales?
- An increase suggests growing market demand and successful commercialization of surgical products, while a decrease may indicate competitive pressure or reduced clinical procedure volumes.
- How does office and surgical — net sales compare across companies?
- Comparable to medical device revenue segments at peer companies, often evaluated against broader surgical equipment and clinical supply market growth rates.